Richard C Mohs

Biographic Data

ID9096029
NAMERichard C Mohs
GIVEN NAMESRichard C
FAMILY NAMEMohs
SIGNATUREMOHS R C
AFFILIATIONSIcahn School of Medicine at Mount Sinai
ORCID0000-0002-3765-6287
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1989
LATEST PUBLICATION YEAR2012
H-INDEX0

  • The Effect of Duloxetine Treatment on Cognition in Patients With Fibromyalgia

    Richard Mohs, Richard C Mohs et al.ARTICLEPsychosomatic Medicine2012

    OBJECTIVES: To determine the effect of duloxetine treatment on cognition in patients with fibromyalgia. METHODS: Cognitive testing was conducted in a subset of adult patients in a randomized, double-blind, placebo-controlled trial of duloxetine. Patients met the American College of Rheumatology criteria for fibromyalgia and had a score of 4 or higher on the Brief Pain Inventory 24-hour average pain severity item. Patients who consented to cogniti…

  • The diagnosis of dementia due to Alzheimer's disease

    Open AccessGuy M Mckhann, David S Knopman et al.ARTICLEAlzheimer's & Dementia2011

    The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or i…

  • Current Concepts in Mild Cognitive Impairment

    Ronald C Petersen, Rachelle S Doody et al.ARTICLEArchives of Neurology2001

    The field of aging and dementia is focusing on the characterization of the earliest stages of cognitive impairment. Recent research has identified a transitional state between the cognitive changes of normal aging and Alzheimer's disease (AD), known as mild cognitive impairment (MCI). Mild cognitive impairment refers to the clinical condition between normal aging and AD in which persons experience memory loss to a greater extent than one would ex…

  • High, usual and impaired functioning in community-dwelling older men and women

    Open AccessLisa F Berkman, Lisa Berkman et al.ARTICLEJournal of Clinical Epidemiology1993

  • The Consortium to Establish a Registry for Alzheimer's Disease (Cerad). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

    Open AccessJ C Moms, Albert Heyman et al.ARTICLENeurology1989

    The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed brief, comprehensive, and reliable batteries of clinical and neuropsychological tests for assessment of patients with the clinical diagnosis of Alzheimer's disease (AD). We administered these batteries in a standardized manner to more than 350 subjects with a diagnosis of AD and 275 control subjects who were enrolled in a nationwide registry by a consortium of 16…